Atlas Trials

A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927

Clinical trial NCT00800215 · COMPLETED

Trial details

NCT number
NCT00800215
Sponsor
UCB Pharma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Epilepsy
Start date
2004-03-04
Primary completion
2004-08-17
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.